Hospira, a biosimilar injectables specialist now belonging to US pharma giant Pfizer, has been ordered to pay $70 million for infringing a patent belonging to A 25 September 2017
Pharma giant Pfizer has filed a US lawsuit against Johnson & Johnson, accusing the healthcare firm of using exclusionary contracts and other 'anticompetitive' p 21 September 2017
The generics and biosimilars industry has released a document claiming that the US government could save over $10 billion in a decade if the Centers for Medicar 20 September 2017
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.